York Space Systems earnings release, May 14, 2026

York Space Systems Inc. (YSS) · Form 8-K, Item 2.02 · Filed · SEC filing

York Space Systems Reports First Quarter 2026 Results

Government and Commercial Wins Reinforce Execution as Company Accelerates Expansion

DENVER, CO—May 14, 2026 – York Space Systems Inc. (NYSE: YSS) (York) today announced financial results for the quarter ended March 31, 2026.

* See definition and reconciliation of Adjusted EBITDA to net loss under “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Measures.”

“Our Q1 results reflect consistent execution against the objectives we set at the start of the year and with our IPO. Our commercial momentum and IDIQ awards demonstrate continued traction, and after quarter end, our agreement to acquire ALL.SPACE represents a meaningful step in expanding our total addressable market and broadening the range of missions we can support,” said Dirk Wallinger, CEO of York. “We are actively investing ahead of demand by building inventory of our satellite platforms and aligning our operations to support faster deployment timelines. That readiness is increasingly important as customers prioritize resilient, proliferated architectures and communications capabilities that can perform in more complex operating environments. Our focus remains on disciplined execution, continuing to build capacity, integrate new capabilities, and convert opportunity into awarded work.”

“The team is executing well and driving strong growth,” said Kevin Messerle, CFO of York. “Given the breadth of demand in front of us, we remain disciplined in how we allocate capital to maximize long-term value. The IPO has given us the opportunity to accelerate our growth by entering new but adjacent markets and building our new business footprint in the U.S. and across the world.”

First Quarter 2026 Company Results

Revenue increased $10 million, or 9%, to $116 million. This increase was primarily driven by growth in our major government programs.

Gross Margin decreased 4 percentage points to 19%;

Gross Profit decreased 10% to $22 million. The decrease in gross margin is largely attributable to unfavorable EAC adjustments taken in the quarter together with favorable EAC adjustments in the year-ago quarter; the decrease in gross profit is primarily driven by the same, offset by higher revenue.

Backlog increased to

$642 million reflecting the new commercial contract signed in first quarter of 2026.

Selected highlights

• York completed its IPO, raising net proceeds of $583 million.

• York acquired Orbion Space Technology, strengthening its supply chain with flight-proven electric propulsion systems.

• York secured a 12-month extension from NASA and Johns Hopkins Applied Physics Laboratory (APL) for its BARD mission. This enables an expanded series of demonstrations of the Polylingual Experimental Terminal (PExT) payload throughout 2026 and into early 2027, including increased interoperability testing and direct-to-Earth (DTE) communications with commercial ground service providers, supporting near real-time commanding, telemetry, and science data transfer options for future science and operational missions.

• York was awarded multiple IDIQ contract awards across two mission areas critical to national security and defense. York will compete for, and is well-positioned to win and execute, task orders under these awards. These awards expand York’s role in next-generation space and defense architectures.

• York finalized a multi-year $187 million commercial contract for a 20+ satellite constellation built on the M-CLASS platform, demonstrating continued growth in the commercial market.

• York initiated build-out of the first 20 satellite platforms for inventory, leveraging its mature production capacity and Manufacturing Readiness Level (MRL) 9 capabilities to accelerate time-to-orbit and meet growing demand for rapid, large-quantity deployments from government and commercial customers.

• In April 2026, York announced the entry into a definitive agreement to acquire ALL.SPACE, a leading provider of advanced satellite communications terminals and multi-network connectivity solutions. With the acquisition, York is creating a complete communications ecosystem that operates in contested environments across commercial and government networks. The consummation of the acquisition is subject to regulatory approvals and customary closing conditions.

Liquidity

As of March 31, 2026, our cash and cash equivalents were $656 million and availability under our Revolving Facility was $150 million, for total liquidity of $806 million.

Business outlook as of May 14, 2026

We are reaffirming our revenue guidance range of $545 million to $595 million for the full year 2026, as provided on our March 19, 2026 press release.

*Business outlook is based on information as of today, May 14, 2026, and may be impacted by factors outside York’s control. See “Forward Looking Statements.”

Conference Call

York will host a conference call to review its financial results for the first quarter 2026 and its outlook for the future and may disclose other material developments affecting its business and/or financial performance. Listeners may access the conference call live via audio webcast.

Thursday May 14, 2026

3:00 pm Mountain Time (5:00 pm Eastern Time)

Webcast: https://events.q4inc.com/attendee/615953366

An audio webcast replay of the conference call will be available for one year at http://ir.yorkspacesystems.com.

About York Space Systems

York Space Systems... (truncated)in the U.S. government’s mission needs and procurement processes.

Financial statements

Income Statement

For the three months ended March 31, — DENVER, CO—May 14, 2026 – York Space Systems Inc. (NYSE: YSS) (York) today announced financial results for the quarter ended March 31, 2026. ($ in thousands, except percentages)

For the three months ended March 31, – 2026For the three months ended March 31, – 2025% Change
Revenue116,343106,2529.0%
Gross profit22,15024,602-10.0%
Net loss-114,842-11,729879.0%
Adjusted EBITDA (non-GAAP)-3,6385,454-167.0%

Income Statement

For the three months ended March 31, — Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) ($ in thousands, except shares and per share amounts)

For the three months ended March 31, – 2026For the three months ended March 31, – 2025
Revenue116,343106,252
Cost of revenues94,19381,650
Gross profit22,15024,602
Operating expensesSelling, general and administrative expenses36,70626,801
Operating expensesStock compensation expense84,696
Operating expensesResearch and development expenses5,2894,401
Operating expensesTransaction costs5,92531
Operating expensesTotal operating expenses132,61631,233
Operating expensesLoss from operations-110,466-6,631
Other (expense) incomeInterest expense-2,899-7,059
Other (expense) incomeInterest income4,620541
Other (expense) incomeOther income (expense), net-6,207114
Other (expense) incomeTotal other expense-4,486-6,404
Other (expense) incomeLoss before provision for income taxes-114,952-13,035
Other (expense) incomeIncome tax benefit1101,306
Other (expense) incomeNet loss-114,842-11,729
Other (expense) incomeForeign currency translation adjustment-121485
Other (expense) incomeComprehensive loss-114,963-11,244
Net loss per common shareNet loss-114,842-11,729
Net loss per common shareLess: Accretion of Class P Units192
Net loss per common shareLess: Deemed dividend on Conversion of the Class P Units upon IPO60,722
Net loss per common shareNet loss available to common shareholders-175,756-11,729
Net loss per common shareBasic and diluted net loss per share$—
Weighted average common shares outstandingBasic and diluted weighted common shares outstanding116,022,67695,141,928

Income Statement

For the three months ended March 31, — (Unaudited) ($ in thousands, except percentages)

For the three months ended March 31, – 2026For the three months ended March 31, – 2025
Revenue116,343106,252
Less: Cost of revenues94,19381,650
Gross profit (GAAP)22,15024,602
Gross profit % (GAAP)19.0%23.0%
Add: Direct labor costs10,1557,724
Add: Direct overhead costs3,3431,715
Add: Depreciation and amortization4,4181,262
Contribution margin (non-GAAP)40,06635,303
Contribution margin % (non-GAAP)34.0%33.0%

Income Statement

For the three months ended March 31, — (Unaudited) (in thousands)

For the three months ended March 31, – 2026For the three months ended March 31, – 2025
Net loss-114,842-11,729
Interest expense2,8997,059
Interest income-4,620-541
Income tax benefit-110-1,306
Depreciation and amortization16,10312,036
EBITDA (non-GAAP)-100,5705,519
Changes in the fair value of derivatives4,830-142
Stock-based compensation expense84,696
Transaction costs(1)5,92531
Other(2)1,48146
Adjusted EBITDA (non-GAAP)-3,6385,454

Balance Sheet

As of March 31, 2026 — Condensed Consolidated Balance Sheets (Unaudited) (in thousands)

As of March 31, 2026As of December 31, 2025
Cash and cash equivalents655,693162,573
Accounts receivable, net3,93111,539
Inventories34,20618,747
Prepaid expenses and other current assets16,20331,478
Contract assets96,57376,809
Capitalized commissions, net5,1076,661
Total current assets811,713307,807
Fixed assets, net49,94646,293
Right of use assets, net28,74724,683
Goodwill737,385674,262
Other intangibles, net414,916407,925
Other assets6,34714,415
Total assets2,049,0541,475,385
Current liabilitiesContract liabilities28,565110,275
Current liabilitiesAccounts payable and accrued expenses103,65468,358
Current liabilitiesOperating lease liabilities, current4,0743,260
Current liabilitiesIncome taxes payable528672
Current liabilitiesLong-term debt, current4,6883,750
Current liabilitiesDeferred commissions, current5,3915,038
Current liabilitiesTotal current liabilities146,900191,353
Current liabilitiesOperating lease liabilities, less current portion26,42523,161
Current liabilitiesDeferred commissions, less current portion1,1272,110
Current liabilitiesLong-term debt, net143,189144,962
Current liabilitiesDerivative liability associated with Class P Units93,411
Current liabilitiesOther liabilities3,4053,353
Current liabilitiesDeferred income tax liability5,6576,096
Current liabilitiesTotal liabilities326,703464,446
Temporary EquityClass P Units (240,956,348 and 0 units authorized, issued and outstanding at December 31, 2025 and 2024, respectively; $241,498 and $0 liquidation preference as of December 31, 2025 and 2024, respectively)143,115
Member's Capital/Stockholders EquityCommon units (0 and 50,000,000 authorized, issued and outstanding at March 31, 2026 and December 31, 2025, respectively)1,135,910

Balance Sheet

Condensed Consolidated Balance Sheets (Unaudited)

Common stock ($0.0001 par value per share; 1,000,000,000 and 0 authorized at March 31, 2026 and December 31, 2025, respectively; 127,609,213 and 0 issued and outstanding at March 31, 2026 and December 31, 2025, respectively)13

Cash Flow

For the three months ended March 31, — Condensed Consolidated Statements of Cash Flows (Unaudited) (in thousands)

For the three months ended March 31, – 2026For the three months ended March 31, – 2025
Net loss-114,842-11,729
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Depreciation and amortization16,10312,036
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Stock compensation expense84,696
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Amortization of debt issuance costs207
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Non-cash lease expense980209
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Amortization of capitalized commissions1,514636
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Deferred taxes-503-1,298
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Loss on equity investment1,538
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:Other, net5,789-142
Changes in assets and liabilities, net of the effect of acquisitions:Accounts receivable, net8,232-613
Changes in assets and liabilities, net of the effect of acquisitions:Inventories-16,0368,962
Changes in assets and liabilities, net of the effect of acquisitions:Prepaid expenses and other current assets11,1252,819
Changes in assets and liabilities, net of the effect of acquisitions:Contract assets-19,764-43,027
Changes in assets and liabilities, net of the effect of acquisitions:Other long-term assets-77-5
Changes in assets and liabilities, net of the effect of acquisitions:Contract liabilities-84,726-58,912
Changes in assets and liabilities, net of the effect of acquisitions:Accounts payable and accrued expenses22,96510,668
Changes in assets and liabilities, net of the effect of acquisitions:Deferred commissions-630-1,255
Changes in assets and liabilities, net of the effect of acquisitions:Income taxes payable-131
Changes in assets and liabilities, net of the effect of acquisitions:Related party payables626
Changes in assets and liabilities, net of the effect of acquisitions:Other long-term liabilities7183
Changes in assets and liabilities, net of the effect of acquisitions:Right-of-use assets and operating lease liabilities, net-966-598
Changes in assets and liabilities, net of the effect of acquisitions:Net cash (used in) operating activities-84,455-79,496
Cash flows from investing activitiesCapital expenditures-2,148-1,173
Cash flows from investing activitiesEquity investments-3,150
Cash flows from investing activitiesAcquisition of business, net of cash acquired-10,778
Cash flows from investing activitiesIssuance of notes receivable-2,500
Cash flows from investing activitiesProceeds from settlement of notes receivable5,000
Cash flows from investing activitiesNet cash (used in)/provided by investing activities-11,076-3,673
Cash flows from financing activitiesProceeds from issuance of common stock in connection with the IPO, net of underwriting discounts and commissions592,833
Cash flows from financing activitiesPayment of offering costs in connection with the IPO-3,192
Cash flows from financing activitiesRepayment of principal on long-term debt-938
Cash flows from financing activitiesNet cash provided by financing activities588,703
Cash flows from financing activitiesNet increase/(decrease) in cash and cash equivalents493,172-83,169
Cash flows from financing activitiesEffect of exchange rate changes on cash-5265

Cash Flow

Condensed Consolidated Statements of Cash Flows (Unaudited)

Cash and cash equivalents, beginning of period162,573104,656
Cash at end of period655,69321,552
Supplemental disclosures of cash flow informationCash payments for interest3,0646,292
Supplemental disclosures of cash flow informationCash (refunded)/paid for taxes-14
Noncash operating, investing, and financingChanges in accounts payable and accruals for purchases of fixed assets1,343358
Noncash operating, investing, and financingConversion of common units into shares of common stock upon IPO1,135,718
Noncash operating, investing, and financingConversion of Class P Units into shares of common stock upon IPO241,391
Noncash operating, investing, and financingIssuance of common shares for acquisition of Orbion60,180
Full release

Forward-Looking Statements

This press release and the related conference call contain “forward-looking statements” within the meaning of, and we intend such forward-looking statements to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. In particular, statements about our 2026 outlook, future revenue and growth prospects, backlog, growth of market share and addressable market, growth and M&A strategy, business plans, inventory building, expectations regarding government agencies, programs and actions, the timing and consummation of the acquisition of ALL.SPACE, benefits expected from the acquisitions of Orbion Space Technology and ALL.SPACE, the future health of our spacecraft, the markets in which we operate, including growth of our various markets, potential new products and product innovation and our expectations, contract performance, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance contained in this press release and made during the related conference call, are forward-looking statements.

Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include: disruptions in U.S. government operations and funding and budgetary priorities of the U.S. government; limitations on investor insight into portions of our business due to our classified contracts with the U.S. government; our failure to establish and maintain important relationships with government agencies and prime contractors; the potential inability to realize our backlog; difficulties or disruptions in consummating future acquisitions and integrating the operations of acquired companies into our business, and in realizing the expected benefits of these transactions, including with respect to Orbion Space Technology and ALL.SPACE, cost overruns on our contracts, including before final receipt of a contract; concentration of our customers and backlog; our failure to implement and maintain an effective system of internal control over financial reporting; fluctuation of our operating results; significant competition in the global space and satellite market; our failure to manage our growth effectively and our ability to achieve and maintain profitability; any failure of our spacecraft systems and related software to operate as intended, resulting in warranty claims for product failures, schedule delays or other problems with existing or new products; our revenue, results of operations and reputation may be negatively impacted if our products contain defects or fail to operate in the expected manner; our dependence on contracts entered into in the ordinary course of business and our dependence on major customers and vendors; the scarcity or unavailability of critical components used to manufacture our products or used in our development programs; the emerging and shifting nature of the market for spacecraft platforms and satellite software and its failure to achieve the growth potential we expect; uncertain global macro-economic and political conditions, including the implementation of tariffs; a failure of our information technology systems, physical or electronic security protections; the failure to adequately protect our proprietary intellectual property rights; the inability to comply with any of our contracts or meet eligibility requirements to obtain certain government contracts; government laws and regulations, particularly those relating to contracting in the defense industry; our substantial indebtedness; and the other factors set forth in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date of this press release and the related conference call. Actual results may vary from the estimates provided. We undertake no intent or obligation to publicly update or revise any of the estimates and other forward-looking statements made in this press release, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

We believe that in addition to our results determined in accordance with U.S. generally accepted accounting principles (“GAAP”), our non-GAAP financial measures including contribution margin, contribution margin %, EBITDA, and Adjusted EBITDA provide useful information to management, investors, and analysts in assessing our financial performance and results of operations across reporting periods by excluding items we do not believe are indicative of our core operating performance. In addition to our GAAP measures, we use these non-GAAP financial measures to evaluate our operating performance, generate future operating plans, and make strategic decisions, including those relating to operating expenses and the allocation of internal resources, including budgeting for infrastructure.

These non-GAAP financial measures are used to supplement the financial information presented on a GAAP basis and should not be considered in isolation or as a substitute for the relevant GAAP measures and should be read in conjunction with information presented on a GAAP basis. Because not all companies use identical calculations, our presentation of non-GAAP measures may not be comparable to other similarly titled measures of other companies.... (AP financial measures are limited in value because they exclude certain items that may have a material impact on our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which items are adjusted to calculate our non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in our public disclosures.

Contribution Margin

We refer to revenue less direct material costs of revenue as “contribution margin” and contribution margin divided by revenue as “contribution margin %.” The closest comparable GAAP financial measures to contribution margin and contribution margin % are gross profit and gross profit margin %, respectively. We believe contribution margin and contribution margin % are useful measures of the variable costs that we incur in order to provide services to our customers. Our presentation of contribution margin and contribution margin % should not be construed as an inference that our future results will be unaffected by variable costs.

EBITDA and Adjusted EBITDA

We define EBITDA as net income (loss) adjusted for interest expense, interest income, income tax benefit, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted for changes in the fair value of derivatives, stock-based compensation expense, transaction costs, and other non-recurring items. Net loss is the most directly comparable GAAP measure to Adjusted EBITDA. Our presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, see the “Reconciliation of GAAP to Non-GAAP Results” table in this press release.

Backlog

We view backlog as a key measure of our business growth. Backlog represents our estimate of the revenue we expect to realize in future periods as a result of performing work on contracts that have been awarded to us (net of any revenue already recognized as of the backlog date). We include the aggregate expected revenue of awarded contracts in our backlog upon the execution of a legally binding agreement, even though our contracts include certain termination rights exercisable by our customers with advance notice. We exclude unexercised contract options from our backlog. Contract liabilities recognized on our consolidated balance sheets consists of payments and billings that we have received in excess of revenue that we have recognized. Because cash receipts from these contracts have not been recognized into revenue, they are included in our backlog calculation.

We monitor our backlog because we believe it is a forward-looking indicator of potential sales which can be helpful to investors in evaluating the performance of our business and identifying trends over time. Although backlog reflects business associated with contracts that are considered to be firm, terminations, amendments, or contract cancellations may occur, which could result in a reduction in our total backlog and potential future revenue that is never recognized.

Investor Contact

Christopher Evenden ir@yorkspacesystems.com

Media Contact

Sarah Nickell

Sarah.nickell@yorkspacesystems.com

APPENDIX - 1

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

Condensed Consolidated Balance Sheets (Unaudited)

Condensed Consolidated Statements of Cash Flows (Unaudited)

APPENDIX - 2

Reconciliation of GAAP to Non-GAAP Results

Contribution Margin

(Unaudited)

Reconciliation to Contribution Margin

(Unaudited)

Reconciliation of Net Loss to Adjusted EBITDA

(Unaudited)

(1)

Represents costs for legal, advisory fees and other costs incurred in connection with the Company's acquisition activity and one-time IPO costs.

(2)

Other includes loss on initial Orbion investment, net gain on foreign exchange and one-time non-cash expense.

Backlog

(Unaudited)

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · York Space Systems earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.